Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Invest Ophthalmol Vis Sci ; 65(4): 6, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38564194

ABSTRACT

Purpose: Antibodies against collagen XIII have previously been identified in patients with active thyroid-associated ophthalmopathy (TAO). Although collagen XIII expression has been described in extraocular muscles and orbital fat, its detailed localization in extraocular and thyroid tissues and the connection to autoimmunity for collagen XIII remain unclear. Our objective was to map the potential targets for these antibodies in the tissues of the orbit and thyroid. Methods: We evaluated the expression of collagen XIII in human patient and mouse orbital and thyroid tissues with immunostainings and RT-qPCR using Col13a1-/- mice as negative controls. COL13A1 expression in Graves' disease and goiter thyroid samples was compared with TGF-ß1 and TNF, and these were also studied in human thyroid epithelial cells and fibroblasts. Results: Collagen XIII expression was found in the neuromuscular and myotendinous junctions of extraocular muscles, blood vessels of orbital connective tissue and fat and the thyroid, and in the thyroid epithelium. Thyroid expression was also seen in germinal centers in Graves' disease and in neoplastic epithelium. The expression of COL13A1 in goiter samples correlated with levels of TGF-B1. Upregulation of COL13A1 was reproduced in thyroid epithelial cells treated with TGF-ß1. Conclusions: We mapped the expression of collagen XIII to various locations in the orbit, demonstrated its expression in the pathologies of the Graves' disease thyroid and confirmed the relationship between collagen XIII and TGF-ß1. Altogether, these data add to our understanding of the targets of anti-collagen XIII autoantibodies in TAO.


Subject(s)
Goiter , Graves Disease , Graves Ophthalmopathy , Humans , Animals , Mice , Graves Ophthalmopathy/genetics , Orbit , Transforming Growth Factor beta1 , Collagen , Antibodies
2.
J Cardiovasc Pharmacol ; 62(4): 394-6, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23921312

ABSTRACT

Amiodarone is a commonly prescribed and one of the most effective anti-arrhythmic drugs available. However, its use is limited by serious toxic adverse effects including optic neuropathy. Previously, amiodarone-associated optic neuropathy has been reported at an incidence of 1.3%-1.8%. Nearly, one-third of patients with amiodarone-induced toxic optic neuropathy are asymptomatic and typically visual acuity improves after drug cessation. We describe the case of a 75-year-old woman who experienced severe optic neuropathy with bilateral optic disc edema and hemorrhages, irreversible loss of vision, and severe defects in visual fields after 1.5 months use of amiodarone. The optic disc edema resolved promptly after discontinuation of the drug, but the patient remained blind permanently. This is the first report of only 6.5 weeks of amiodarone treatment resulting in bilateral optic neuropathy with bilateral and irreversible loss of vision. To ideally establish a connection between amiodarone and optic neuropathy, re-exposure of the patient to the drug should reproduce the symptoms. As a limitation of the study, this was not done in the present case because it would have been unethical. The worldwide growth of the elderly population in number is expected to increase age-related conditions including cardiac diseases. The use of cardiovascular drugs, also anti-arrhythmic agents such as amiodarone, may increase. Thus, clinicians need to be aware of the possibility of drug-induced toxic optic neuropathy, especially if a patient receiving a regimen of amiodarone complains of visual problems.


Subject(s)
Amiodarone/adverse effects , Anti-Arrhythmia Agents/adverse effects , Blindness/chemically induced , Optic Nerve Diseases/chemically induced , Aged , Amiodarone/therapeutic use , Anti-Arrhythmia Agents/therapeutic use , Female , Humans , Optic Nerve Diseases/pathology , Papilledema/chemically induced , Papilledema/pathology , Severity of Illness Index , Time Factors , Visual Fields/drug effects
3.
J Neurosci ; 30(43): 14490-501, 2010 Oct 27.
Article in English | MEDLINE | ID: mdl-20980607

ABSTRACT

Although the Schwann cell basement membrane (BM) is required for normal Schwann cell terminal differentiation, the role of BM-associated collagens in peripheral nerve maturation is poorly understood. Collagen XV is a BM zone component strongly expressed in peripheral nerves, and we show that its absence in mice leads to loosely packed axons in C-fibers and polyaxonal myelination. The simultaneous lack of collagen XV and another peripheral nerve component affecting myelination, laminin α4, leads to severely impaired radial sorting and myelination, and the maturation of the nerve is permanently compromised, contrasting with the slow repair observed in Lama4-/- single knock-out mice. Moreover, the Col15a1-/-;Lama4-/- double knock-out (DKO) mice initially lack C-fibers and, even over 1 year of age have only a few, abnormal C-fibers. The Lama4-/- knock-out results in motor and tactile sensory impairment, which is exacerbated by a simultaneous Col15a1-/- knock-out, whereas sensitivity to heat-induced pain is increased in the DKO mice. Lack of collagen XV results in slower sensory nerve conduction, whereas the Lama4-/- and DKO mice exhibit increased sensory nerve action potentials and decreased compound muscle action potentials; x-ray diffraction revealed less mature myelin in the sciatic nerves of the latter than in controls. Ultrastructural analyses revealed changes in the Schwann cell BM in all three mutants, ranging from severe (DKO) to nearly normal (Col15a1-/-). Collagen XV thus contributes to peripheral nerve maturation and C-fiber formation, and its simultaneous deletion from neural BM zones with laminin α4 leads to a DKO phenotype distinct from those of both single knock-outs.


Subject(s)
Basement Membrane/physiology , Collagen/genetics , Collagen/physiology , Laminin/genetics , Laminin/physiology , Peripheral Nerves/physiology , Somatosensory Disorders/genetics , Action Potentials/physiology , Animals , Axons/physiology , Axons/ultrastructure , Basement Membrane/ultrastructure , Behavior, Animal/physiology , Electrophysiology , Enzyme-Linked Immunosorbent Assay , Male , Mice , Mice, Knockout , Microscopy, Immunoelectron , Motor Neurons/physiology , Myelin Sheath/physiology , Nerve Fibers, Unmyelinated/physiology , Neural Conduction/physiology , Peripheral Nerves/ultrastructure , Physical Stimulation , Reflex/physiology , Sensory Receptor Cells/physiology , Sensory Thresholds/physiology , Somatosensory Disorders/physiopathology , X-Ray Diffraction
4.
J Biol Chem ; 285(8): 5258-65, 2010 Feb 19.
Article in English | MEDLINE | ID: mdl-20040604

ABSTRACT

The C-terminal end of collagen XV, restin, has been the focus of several studies, but the functions of full-length collagen XV have remained unknown. We describe here studies on the production, purification, and function of collagen XV and the production of a monoclonal N-terminal antibody to it. Full-length human collagen XV was produced in insect cells using baculoviruses and purified from the cell culture medium. The yield was 15 mg/liter of cell culture medium. The collagen XV was shown to be trimeric, with disulfide bonds in the collagenous region. Rotary shadowing electron microscopy revealed rod-like molecules with a mean length of 241.8 nm and with a globular domain at one end. The globular domain was verified to be the N-terminal end by N-terminal antibody binding. The molecules show flexibility in their conformation, presumably due to the many interruptions in their collagenous domains. The ability of collagen XV to serve as a substrate for cells was tested in cell adhesion assays, and it was shown that cells did not bind to collagen XV-coated surfaces. When added to the culture medium of fibroblasts and fibrosarcoma cells, however, collagen XV rapidly bound to their fibronectin network. Solid phase assays showed that collagen XV binds to fibronectin, laminin, and vitronectin and that it binds to the collagen/gelatin-binding domain of fibronectin. No binding was detected to fibrillar collagens, fibril-associated collagens, or decorin. Interestingly, collagen XV was found to inhibit the adhesion and migration of fibrosarcoma cells when present in fibronectin-containing matrices.


Subject(s)
Collagen/chemistry , Animals , Cell Adhesion/drug effects , Cell Line, Tumor , Cell Movement/drug effects , Collagen/genetics , Collagen/isolation & purification , Collagen/pharmacology , Decorin , Extracellular Matrix Proteins/chemistry , Fibroblasts/metabolism , Fibronectins/chemistry , Fibrosarcoma/metabolism , Humans , Laminin/chemistry , Protein Binding/physiology , Protein Structure, Tertiary/physiology , Proteoglycans/chemistry , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/pharmacology , Vitronectin/chemistry
5.
FASEB J ; 19(11): 1564-6, 2005 Sep.
Article in English | MEDLINE | ID: mdl-15976268

ABSTRACT

Type XVIII collagen is important in the early phase of retinal vascular development and for the regression of the primary vasculature in the vitreous body after birth. We show here that the retina in Col18a1-/- mice becomes densely vascularized by anomalous anastomoses from the persistent hyaloid vasculature by day 10 after birth. In situ hybridizations revealed normal VEGF mRNA expression, but the phenotype of collagen XVIII deficient mice closely resembled that of mice expressing VEGF120 and VEGF188 isoforms only, suggesting that type XVIII collagen may be involved in VEGF function. Type XVIII collagen was found to be indispensable for angiogenesis in the eye, as also oxygen-induced neovascularization was less intense than normal in the Col18a1-/- mice. We observed a marked increase in the amount of retinal astrocytes in the Col18a1-/- mice. Whereas the retinal vessels of wild-type mice are covered by astrocytes and the regressing, thin hyaloid vessels are devoid of astrocytes, the retinal vessels in the Col18a1-/- mice were similarly covered by astrocytes but not the persistent hyaloid vessels in the vitreous body. Interestingly, double null mice lacking type XVIII collagen and its homologue type XV collagen had the persistent hyaloid vessels covered by astrocytes, including the parts located in the vitreous body. We thus hypothesize that type XV collagen is a regulator of glial cell recruitment around vessels and that type XVIII collagen regulates their proliferation.


Subject(s)
Collagen Type XVIII/physiology , Collagen/physiology , Endostatins/physiology , Neovascularization, Physiologic , Neuroglia/physiology , Retina/pathology , Retinal Vessels/physiology , Animals , Astrocytes/physiology , Cell Movement , Collagen Type XVIII/deficiency , Mice , Mice, Inbred C57BL , Oxygen/pharmacology , Platelet-Derived Growth Factor/genetics , RNA, Messenger/analysis , Vascular Endothelial Growth Factor A/genetics , Vitreous Body/blood supply
6.
Invest Ophthalmol Vis Sci ; 54(12): 7450-62, 2013 Nov 13.
Article in English | MEDLINE | ID: mdl-24135756

ABSTRACT

PURPOSE: Collagen XVIII deficiency leads to anterior and posterior eye defects in Col18a1(-/-) mice, and overexpression of its C-terminal endostatin domain under a K14 promoter leads to cataract. We studied the consequences of K14-driven overexpression of the thrombospondin-1 (Tsp-1)-like domain, and also the roles of the three collagen XVIII isoforms in mice specifically lacking either the promoter 1-derived short or the promoter 2-derived medium/long isoforms. METHODS: Two transgenic lines were generated and compared to Col18a1(-/-) and promoter 1 and 2 knockouts. Enucleated eyes were analyzed histopathologically, immunohistochemically, biochemically, and ultrastructurally. IOP was measured by noninvasive tonometry, and the anterior chamber was studied in vivo using a slit-lamp and optical coherence tomography. RESULTS: Overexpression of the Tsp-1 transgene in an FVB/N background resulted in increased axial length, and substantial incidences of cataract, lens subluxation, phthisis, retinal ablation, corneal vascularization, and intraocular hemorrhages. The FVB/N Col18a1(-/-) mice were affected similarly. The findings in the knockout and transgenic lines were milder in a C57BL/6JOlaHsd (B6) background. Studies with the promoter-specific knockouts revealed the short isoform as the sole variant in the lens capsule and inner limiting membrane, while the ciliary body, iris, and Bruch's membrane contained short and medium/long isoforms. Lack of the short isoform, but not of the medium/long isoforms, caused aberrant retinal vascularization. CONCLUSIONS: An excess of the collagen XVIII Tsp-1 domain is deleterious in the eye, possibly by impairing certain functions of the full-length molecule. Moreover, the short isoform is the critical variant in the development of the posterior eye structures.


Subject(s)
Cataract/genetics , Collagen Type XVIII/genetics , DNA/genetics , Gene Expression Regulation , Retina/ultrastructure , Retinal Neovascularization/genetics , Thrombospondin 1/genetics , Animals , Blotting, Southern , Blotting, Western , Cataract/metabolism , Cataract/pathology , Collagen Type XVIII/metabolism , Disease Models, Animal , Immunohistochemistry , Mice , Mice, Inbred C57BL , Microscopy, Electron, Transmission , Polymerase Chain Reaction , Retina/metabolism , Retinal Neovascularization/metabolism , Retinal Neovascularization/pathology , Thrombospondin 1/biosynthesis , Tomography, Optical Coherence
SELECTION OF CITATIONS
SEARCH DETAIL